EUVIMEDEUVIMED entdecken
Crossref

Optimizing spray-dried liposomes for pulmonary delivery: impact of lipids composition and of drying parameters using experimental design

Laure-Anne Bya, Tuan Nghia Dinh, Noémie Penoy, Pierre-Yves Sacré, Benedetta Bottero, Didier Cataldo, Erika Hendrickx, Louise Conrard, Brigitte Evrard, Géraldine Piel, Anna Lechanteur

European Journal of Pharmaceutics and Biopharmaceutics · 2026-06 · 223 · 115035

DOI: 10.1016/j.ejpb.2026.115035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026-06. Verfasst von Laure-Anne Bya und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Liege, Laboratory of Pharmaceutical Technology and Biopharmacy, Center for Interdisciplinary Research on Medicines (CIRM), Avenue Hippo…. Hauptthemen laut MEDLINE: Liposomes, Lipids, Drug Delivery Systems, Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Walloon Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liposomes are promising carriers for pulmonary drug delivery due to their biocompatibility and controlled-release properties. However, their stability in aqueous suspension is limited, leading to aggregation and reduced therapeutic efficiency. Converting liposomal dispersions into dry powders for inhalation (DPIs) is a potential strategy to overcome these limitations. Spray-drying (SD) is particularly attractive for this purpose, offering precise control over particle properties along with speed, cost-efficiency, and scalability. Yet, the thermal and mechanical stresses involved in this process and their effects on liposomal integrity remain poorly understood, limiting its broader application. In this study, we developed a systematic framework integrating Design of Experiments (DOE) with scale-up-oriented processing, combining supercritical fluid technology (PGSS) for liposome formation with subsequent spray-drying of high solid content suspensions. Two complementary DoE approaches were applied: DOEA optimized drying parameters and carbohydrate type, testing trehalose and hydroxypropyl-β-cyclodextrin (HPβCD), while DOEB assessed the effects of active pharmaceutical ingredients (APIs) hydrophobicity, lipid composition (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000 (DSPE-PEG2000) percentage), and carbohydrate-to-liposome ratio. Optimized spray-dried powders exhibited preserved liposome structure (mean diameter 20% and fine particle fraction (FPF) > 60%), low residual moisture ( 75%). Mechanistic insights revealed that HPβCD significantly protects liposomes during atomization, while drug retention was governed by PEGylated lipid content, lipid-to-carbohydrate ratio, and API hydrophobicity. Co-encapsulation of clinically relevant drug combinations (formoterol/budesonide and ciclesonide/indacaterol) produced uniform powders with efficient aerosolization, highlighting the therapeutic potential of these formulations. Collectively, these results establish a robust, scalable, and reproducible approach for designing liposomal DPIs, balancing formulation composition, excipient selection, and process parameters. This study demonstrates that strategic integration of scalable technologies can reconcile structural stability, aerodynamic performance, and manufacturability, paving the way for the industrial translation of liposomal dry powders for targeted pulmonary therapies, including asthma and chronic obstructive pulmonary disease (COPD).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesLipidsDrug Delivery SystemsLungSpray DryingAdministration, InhalationDesiccationPowdersParticle SizeTrehalosePolyethylene Glycols2-Hydroxypropyl-beta-cyclodextrinDry Powder InhalersChemistry, PharmaceuticalExcipientsDrug Compounding

Stichwörter der Autor:innen

Design of experimentsDry powder inhalersLiposomeSpray-drying

Substanzen

LiposomesLipidsPowdersTrehalosePolyethylene Glycols2-Hydroxypropyl-beta-cyclodextrinExcipients

Autor:innen und Institutionen

  • University of Liege, Laboratory of Pharmaceutical Technology and Biopharmacy, Center for Interdisciplinary Research on Medicines (CIRM), Avenue Hippocrate 15, 4000 Liege, Belgium.
  • University of Liege, CIRM, Research Support Unit in Chemometrics, Department of Pharmacy, Avenue Hippocrate 15, 4000 Liege, Belgium.
  • University of Liege, Laboratory of Tumor and Development Biology, GIGA-Cancer, Avenue Hippocrate 15, 4000 Liege, Belgium.
  • Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles (ULB), B-6041 Gosselies, Belgium.
  • University of Liege, Laboratory of Pharmaceutical Technology and Biopharmacy, Center for Interdisciplinary Research on Medicines (CIRM), Avenue Hippocrate 15, 4000 Liege, Belgium. Electronic address: anna.lechanteur@uli…

Förderung

  • Walloon Region

Zitieren

APA

Bya, L. A., Dinh, T. N., Penoy, N., Sacré, P. Y., Bottero, B., Cataldo, D., Hendrickx, E., Conrard, L., Evrard, B., Piel, G., & Lechanteur, A. (2026). Optimizing spray-dried liposomes for pulmonary delivery: impact of lipids composition and of drying parameters using experimental design. European Journal of Pharmaceutics and Biopharmaceutics, 223, 115035. https://doi.org/10.1016/j.ejpb.2026.115035

Vancouver

Bya LA, Dinh TN, Penoy N, Sacré PY, Bottero B, Cataldo D, et al. Optimizing spray-dried liposomes for pulmonary delivery: impact of lipids composition and of drying parameters using experimental design. European Journal of Pharmaceutics and Biopharmaceutics. 2026;223:115035. doi:10.1016/j.ejpb.2026.115035

BibTeX
@article{Bya2026,
  author = {Bya, Laure-Anne and Dinh, Tuan Nghia and Penoy, Noémie and Sacré, Pierre-Yves and Bottero, Benedetta and Cataldo, Didier and Hendrickx, Erika and Conrard, Louise and Evrard, Brigitte and Piel, Géraldine and Lechanteur, Anna},
  title = {Optimizing spray-dried liposomes for pulmonary delivery: impact of lipids composition and of drying parameters using experimental design},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  volume = {223},
  pages = {115035},
  doi = {10.1016/j.ejpb.2026.115035}
}
Kostenlos starten →